share_log

Empower Clinics Resumes Trading With New Canadian Stock Symbol, Search For New Auditor and CFO As Company Resumes Growth Strategy

Empower Clinics Resumes Trading With New Canadian Stock Symbol, Search For New Auditor and CFO As Company Resumes Growth Strategy

Empower Clinics以新的加拿大股票代碼恢復交易,隨着公司恢復增長戰略,尋找新的審計師和首席財務官
Accesswire ·  2022/11/08 17:35

Canadian Stock Symbol Changed To EPW On Canadian Securities Exchange

加拿大證券交易所加拿大股票代碼改為EPW

VANCOUVER, BC / ACCESSWIRE / November 8, 2022 / EMPOWER CLINICS INC (CSE:EPW)(OTCQB:EPWCF) ("Empower Clinics" or the "Company"), an integrated healthcare company serving patients through medical centers, telemedicine platforms, a medical device company, and a high complexity medical diagnostics laboratory, announced today that the British Columbia Securities Commission (BCSC) has revoked the cease trade order (CTO) and trading will resume.

溫哥華,BC/ACCESSWIRE/2022年11月8日/Empower Clinics Inc.(CSE:EPW)(場外交易市場:EPWCF)(“Empower Clinics”或“公司”),一家通過醫療中心、遠端醫療平臺、醫療設備公司和高複雜性醫療診斷實驗室為患者提供服務的綜合醫療保健公司今天宣佈,不列顛哥倫比亞省證券委員會(BCSC)已撤銷停止交易令(CTO),將恢復交易。

The Company expects that its common shares will resume trading on the Canadian Securities Exchange (the "CSE") on or about November 8, 2022.

公司預計其普通股將於2022年11月8日左右在加拿大證券交易所(“CSE”)恢復交易。

NEW STOCK SYMBOL FIRST OF MANY NEW CHANGES TO COME AS EMPOWER CLINICS IMPROVES FINANCIAL REPORTING AND AUDITING SYSTEM

新的股票代碼是許多新變化中的第一個,因為賦權診所改善了財務報告和審計系統

The Company announced that it will change its ticker symbol on the CSE from "CBDT" to "EPW". The symbol change is to take effect immediately upon resumption of trading. The change in the ticker symbol is being made to provide greater visibility to the Company's focus on integrated healthcare and full divestment from all cannabis-related business, as well as, to provide consistency with the Company's "EPWCF" stock symbol in the United States.

該公司宣佈,將其在CSE的股票代碼由“CBDT”改為“EPW”。代碼更改將於復牌後立即生效。股票代碼的改變是為了更好地展示公司對綜合醫療保健的關注和對所有與大麻相關的業務的全面撤資,並與公司的“EPWCF”美國的股票代碼。

No action is required by existing shareholders regarding the ticker symbol change.

現有股東不需要就股票代碼的變化採取任何行動。

"Along with our many shareholders and followers, we welcome the resumption of trading of our shares and are looking forward to trading under the new 'EPW' symbol on the CSE," said Steven McAuley, Chairman and CEO of Empower Clinics. "The new symbol directly aligns with the vision of the Company to focus on integrated healthcare and to continue adding significant value to our shareholders." Mr. McAuley continues, "We have endured a difficult time, a difficult auditor, a difficult audit. I am grateful for shareholder patience and support. I appreciate our team members who show up each day, work hard every day, who support patients, distribute products, and make a difference to the lives of people across North America. I thank you, we thank you, for the continued support of all who have an interest in our Company."

Empower Clinics董事長兼首席執行官史蒂文·麥考利表示:“與我們的許多股東和追隨者一起,我們歡迎我們的股票恢復交易,並期待著在CSE以新的‘EPW’代碼進行交易。”新的標誌與公司專注於綜合保健並繼續為我們的股東增加重大價值的願景直接一致。“McAuley先生繼續說道:“我們經歷了一段艱難的時期,一位艱難的審計師,一次艱難的審計。我感謝股東的耐心和支持。我感謝我們的團隊成員,他們每天都出現,每天都在努力工作,他們支持患者,分發產品,並為北美各地的人們的生活做出了改變。我感謝你們,我們感謝你們繼續支持所有對我們公司感興趣的人。”

The Company has filed audited annual financial statements for the year ended December 31, 2021, as well as unaudited condensed interim consolidated financial statements for the three-months ended March 31, 2022, and the six-months ended June 30, 2022, along with the related management's discussion and analysis and required certifications. All filings are available at . The Company has met its continuous disclosure obligations pursuant to securities laws and the revocation orders granted by the securities regulators.

本公司已提交經審計的截至2021年12月31日的年度財務報表,以及截至2022年3月31日的三個月和截至2022年6月30日的六個月的未經審計的簡明中期綜合財務報表,以及相關管理層的討論和分析以及所需的證明。所有的申請檔案都可以在上查閱。本公司已根據證券法及證券監管機構發出的撤銷令履行其持續披露義務。

With respect to additional new changes for the purposes of improving its financial reporting, filing, annual audit process and continuous disclosure requirements, the Company has implemented or anticipates implementing the following initiatives:

關於為改進其財務報告、備案、年度審計程式和持續披露要求而進行的其他新變化,該公司已經實施或預計將實施以下舉措:

1. Search For A New Auditor

1.尋找新的審計師

After repeated audit delays, the Company and its auditor have mutually agreed to end their relationship. Empower Clinics has already begun the search for a new auditor and will advise of an appointment in the near future.

在一次又一次的審計拖延之後,該公司和其審計師共同同意結束他們的關係。Empower診所已經開始尋找新的審計師,並將在不久的將來通知任命。

2. Apply To Change The Fiscal Year End To March 31st To Relieve Pressure On Future Audits

2.申請將財政年度結束改為3月31日ST減輕未來審計工作的壓力

The audit industry has not been immune to staffing shortages that have impacted every industry across North America over the past two years. This major problem is exacerbated by the fact that 57% of Canadian public companies have a year end of December 31st, which results in an almost insurmountable capacity issue, that impacts issuers and appears to be an issue for the foreseeable future. 1)

審計行業也不能倖免於人員短缺的影響,過去兩年,人員短缺影響了整個北美的每個行業。加拿大57%的上市公司的年終日期為12月31日,這導致了幾乎無法克服的能力問題,這影響了發行人,在可預見的未來似乎是一個問題,這加劇了這一主要問題。1)

As such and in consultation with new potential audit firms, the Company will be filing with the CRA an application to change its fiscal year end to March 31st, a period in which only 6.5% share as their year-end. 1)

因此,在與新的潛在審計公司協商後,該公司將向CRA提交申請,將其財政年度結束改為3月31日,在此期間,只有6.5%的股份作為他們的年終。1)

3. Hiring A New Chief Financial Officer

3.招聘新的首席財務官

The Company suddenly and unexpectedly lost its previous Chief Financial Officer due to personal reasons. Empower Clinics will be recruiting and hiring a new CFO with a track record of excellence in financial operations for public companies.

由於個人原因,公司突然意外失去了前首席財務官。Empower診所將招聘和聘用一位在上市公司財務運營方面擁有卓越記錄的新CFO。

4. Re-Listing On Frankfurt Stock Exchange

4.在法蘭克福證券交易所重新上市

We will immediately begin the process of re-listing on the Frankfurt Stock Exchange to support our vast, loyal, and invaluable shareholders in Germany and in German speaking countries. The Company will provide updates on this process as early and as often as possible.

我們將立即開始在法蘭克福證券交易所重新上市的程式,以支持我們在德國和德語國家的廣大、忠誠和寶貴的股東。該公司將盡早並盡可能頻繁地提供有關這一進程的最新情況。

Following a trade resumption and related updates above, the Company anticipates important and meaningful business-related announcements in the days and weeks ahead.

在上述恢復交易和相關更新之後,公司預計在未來幾天和幾周內將發佈與業務相關的重要和有意義的公告。

This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management

本新聞稿可在AGORACOM上的授權診所驗證論壇上獲得,以供股東討論、提問和與管理層接觸


1)

1)

About Empower

關於授權

Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.

Empower是一家綜合性醫療保健公司,通過其診所、數位和遠端醫療護理以及世界級醫療診斷實驗室為患者提供身心健康。在經驗豐富的領導團隊的支持下,Empower正在北美地區積極擴大其臨床和數字業務。我們的健康與健康和診斷與技術業務部門將積極影響我們患者的整體健康,同時為我們的股東提供長期價值。

ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley
Chief Executive Officer

我謹代表董事會:
史蒂文·麥考利
首席執行官

CONTACTS:

聯繫人:

Investors

Tamara Mason

Steven McAuley

Business Development & Communications

CEO

1-855-855-9058

1-855-855-9058

t.mason@empowerclinics.com

s.mcauley@empowerclinics.com

投資者

塔瑪拉·梅森

史蒂文·麥考利

業務發展與溝通

首席執行官

1-855-855-9058

1-855-855-9058

郵箱:t.mason@empower Clinics.com

郵箱:s.mcauley@empower Clinics.com

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

對前瞻性陳述的免責聲明

This news release contains certain "forward-looking statements" or "forward-looking information" (collectively "forward looking statements") within the meaning of applicable Canadian securities laws. Statements other than statements of historical fact are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release, and include statements regarding the Company's ability to positively impact the integrated health of its patients while simultaneously providing long term value for shareholders. Forward-looking statements can frequently be identified by words such as "plans", "continues", "expects", "projects", "intends", "believes", "anticipates", "estimates", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: that the Company will be successful is finding a new auditor; that the Company will receive an approval from the CRA to amend and change the financial year-end of the Company, and that such change will relieve pressure on future audits; that the Company will be successful in hiring a new Chief Financial Officer, or that the Chief Financial Officer will have a track record of excellence in financial operations for public companies; that the Company will be able to re-list on the Frankfurt Stock Exchange; that the Company's products may not work as expected; that the Company may not be able to maintain or expand its current COVID-19 testing; that legislative changes may have an adverse effect on the Company's business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; that general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with any proposed transactions; and other factors beyond the Company's control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

本新聞稿包含適用於加拿大證券法的某些“前瞻性陳述”或“前瞻性資訊”(統稱為“前瞻性陳述”)。除歷史事實陳述外,其他陳述均為前瞻性陳述,以本新聞稿發佈之日的預期、估計和預測為基礎,包括有關該公司在為股東提供長期價值的同時,積極影響患者整體健康的能力的陳述。前瞻性表述常常可以用“計劃”、“繼續”、“預期”、“專案”、“打算”、“相信”、“預期”、“估計”、“可能”、“將”、“潛在”、“建議”和其他類似詞語,或某些事件或條件“可能”或“將”發生的資訊來識別。此類陳述僅為預測,基於管理層目前已知的假設,並受風險和不確定因素的影響,這些風險和不確定性可能導致實際結果、業績或發展與前瞻性陳述中包含的結果、業績或發展大不相同,這些風險和不確定因素包括:公司將在尋找新的審計師方面取得成功;公司將獲得CRA的批准,以修訂和改變公司的財務年終;這種變化將減輕未來審計的壓力;公司將成功聘用新的首席財務官,或首席財務官將在上市公司的財務運營方面擁有卓越的記錄;這些不確定性包括:公司能夠在法蘭克福證券交易所重新上市;公司的產品可能不能像預期的那樣工作;公司可能無法維持或擴大目前的新冠肺炎檢測;法規變化可能對公司的業務和產品開發產生不利影響;公司可能無法獲得足夠的資金來實施其業務計劃;總體業務、經濟、競爭、政治和社會不確定性;任何擬議的交易未能獲得任何必要的批准;以及公司無法控制的其他因素。不能保證前瞻性陳述中預期的任何事件都會發生,或者如果發生了,公司將從中獲得什麼好處。告誡讀者不要過度依賴本新聞稿中的前瞻性陳述,這些前瞻性陳述完全受這些警告性陳述的限制。除適用法律明確要求外,公司沒有義務更新或修改本新聞稿中的任何前瞻性陳述,除非適用法律明確要求,無論是新資訊、未來事件還是其他原因。

SOURCE: Empower Clinics Inc.

資料來源:Empower Clinics Inc.


View source version on accesswire.com:
在Accesswire.com上查看源代碼版本:

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論